Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 33.06 CNY -0.69%
Updated: May 23, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

5.3B
-1%
Assets
Growth Rates:
1 Year
+5%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
2.6B
-7%
Liabilities
Growth Rates:
1 Year
-4%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
2.7B
+5%
Equity
Growth Rates:
1 Year
+16%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Qingdao Baheal Medical Inc

5.3B
Assets
2.6B
Liabilities
5.3B
Assets
2.6B
Liabilities
Current Assets 4.5B
Cash & Short-Term Investments 1B
Receivables 2.4B
Other Current Assets 1B
Non-Current Assets 844.9m
Long-Term Investments 264.3m
PP&E 395.3m
Intangibles 105.3m
Other Non-Current Assets 80m
Current Liabilities 1.8B
Accounts Payable 625.8m
Accrued Liabilities 127.9m
Short-Term Debt 776.8m
Other Current Liabilities 288.4m
Non-Current Liabilities 811.2m
Long-Term Debt 808.4m
Other Non-Current Liabilities 2.8m

Balance Sheet
Qingdao Baheal Medical Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
515
801
947
1 138
786
985
Cash
515
801
968
1 138
786
985
Cash Equivalents
0
0
22
0
0
0
Short-Term Investments
12
0
35
41
27
28
Total Receivables
955
1 254
1 697
1 990
2 286
2 394
Accounts Receivables
881
1 180
1 558
1 857
2 028
2 073
Other Receivables
73
74
139
132
257
322
Inventory
332
487
610
624
650
685
Other Current Assets
344
439
252
300
509
363
Total Current Assets
2 156
2 981
3 541
4 092
4 258
4 454
PP&E Net
179
174
171
226
433
395
PP&E Gross
179
174
171
226
433
395
Accumulated Depreciation
69
77
89
106
154
184
Intangible Assets
37
33
31
29
57
105
Goodwill
6
6
6
6
1
1
Long-Term Investments
171
193
199
210
237
264
Other Long-Term Assets
77
43
52
41
45
80
Other Assets
6
6
6
6
1
1
Total Assets
2 627
N/A
3 430
+31%
4 001
+17%
4 603
+15%
5 030
+9%
5 299
+5%
Liabilities
Accounts Payable
463
571
710
618
601
626
Accrued Liabilities
55
70
82
115
163
128
Short-Term Debt
705
1 350
1 506
1 452
1 607
777
Current Portion of Long-Term Debt
178
0
0
15
27
19
Other Current Liabilities
137
130
199
199
206
269
Total Current Liabilities
1 537
2 120
2 497
2 401
2 604
1 819
Long-Term Debt
0
0
0
22
145
808
Deferred Income Tax
5
4
5
6
1
29
Minority Interest
10
25
27
17
22
26
Total Liabilities
1 552
N/A
2 149
+38%
2 529
+18%
2 446
-3%
2 728
+12%
2 630
-4%
Equity
Common Stock
473
473
473
525
525
526
Retained Earnings
397
607
790
1 212
1 364
1 620
Additional Paid In Capital
205
201
208
418
412
422
Unrealized Security Profit/Loss
0
0
0
1
1
1
Other Equity
0
0
1
2
2
102
Total Equity
1 075
N/A
1 281
+19%
1 472
+15%
2 157
+47%
2 302
+7%
2 668
+16%
Total Liabilities & Equity
2 627
N/A
3 430
+31%
4 001
+17%
4 603
+15%
5 030
+9%
5 299
+5%
Shares Outstanding
Common Shares Outstanding
525
525
525
525
525
526

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.